A new analysis published by Avalere Health found that the proposed GLOBE (Global Benchmark for Efficient Drug Pricing) Model would have…
For decades, rising costs of health care, health insurance, and prescription drugs have been a major concern for American consumers, caregivers,…
Aimed Alliance recently sent a letter urging the Virginia House Labor and Commerce Committee to reconsider House Bill 483, which…
On January 5, the Centers for Disease Control and Prevention (CDC) Acting Director Jim O’Neill announced significant updates to the…
Aimed Alliance is pleased to share two new resources on prescription drug affordability boards (PDABs). PDABs are established at the…
Gold card laws exempt healthcare providers from prior authorization if they have a high approval rate, reducing delays in patient…
On December 10, 2025, Representatives Rudy Yakym (R-IN) and André Carson (D-IN) introduced the Safeguarding Americans from Fraudulent and Experimental…
On December 5, 2025, Aimed Alliance’s Counsel, Michael Barnes, published a new opinion piece titled “Trump Administration Took Decisive Action…
Aimed Alliance has released a new fact sheet explaining the role of the U.S. Trade Representative (USTR) in shaping international…
Earlier this month, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment initiative aimed at addressing…